Related Experiment Video
Updated: May 21, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Human cytomegalovirus linked to stroke in a Chinese population
Zheng-Rong Huang1, Li-Ping Yu, Xin-Chun Yang
1The First Affiliated Hospital, Xiamen University Medical School, Xiamen, China.
Insights
Human cytomegalovirus (HCMV) infection is linked to a higher risk of stroke. This study found a significant association between HCMV and both ischemic and hemorrhagic stroke subtypes.
Area of Science:
- Infectious Diseases
- Neurology
- Cardiovascular Science
Background:
- Human cytomegalovirus (HCMV) is associated with cardiovascular diseases.
- The role of HCMV in stroke pathogenesis requires further investigation.
Purpose of the Study:
- To evaluate the relationship between HCMV infection and stroke.
- To determine if HCMV is a risk factor for stroke development.
Main Methods:
- Plasma samples from 200 stroke patients and 200 controls were analyzed.
- Real-time PCR and ELISA were used to detect HCMV infection.
- Data were collected from the Stroke Hypertension Investigation in Genetics (SHINING) study.
Main Results:
- HCMV seropositivity was significantly higher in stroke patients (55.0%) compared to controls (23.5%).
- HCMV presence increased the risk of stroke by approximately fourfold (OR, 3.98).
- This association remained significant for both ischemic and hemorrhagic stroke subtypes after adjusting for major risk factors.
Conclusions:
- A novel link between HCMV infection and stroke is demonstrated.
- HCMV may play a role in the pathogenesis of stroke.
- Further research is warranted to explore HCMV's impact on stroke.
Aim:
Human cytomegalovirus (HCMV) is implicated in several cardiovascular disorders, including atherosclerosis, coronary heart disease, and cardiac transplant arteriopathy. We aimed to evaluate the relationship between HCMV and stroke.
Methods:
Real-time polymerase chain reaction (PCR) and ELISA were performed on plasma samples isolated from 200 patients diagnosed with stroke and 200 controls. All participants belonged to the Stroke Hypertension Investigation in Genetics (SHINING) study.
Results:
HCMV seropositivity was higher in the stroke group than in controls (55.0% vs. 23.5%; P < 0.0001). The presence of HCMV DNA increased the risk of stroke (unadjusted odds ratio [OR], 3.98; 95% confidence interval [CI], 2.59 to 6.11; P < 0.0001). Risks were also increased for the subtypes ischemic stroke (unadjusted OR, 4.01; 95% CI, 2.57-6.24; P < 0.0001) and hemorrhagic stroke (unadjusted OR, 3.80; 95% CI, 1.64-8.78; P= 0.0018). Increased risk with HCMV remained significant after adjustment for age, sex, body mass index, hypertension, and smoking (ischemic stroke: adjusted OR, 4.07; 95% CI, 2.52-6.32; P < 0.0001; hemorrhagic stroke: adjusted OR, 3.88; 95% CI, 1.61-9.36; P= 0.0026).
Conclusions:
We demonstrate a novel link between HCMV infection and stroke. These findings may provide important insights into the pathogenesis of stroke.
Related Concept Videos
Cytomegalovirus Disease
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Single Nucleotide Polymorphisms-SNPs

